Detlef Albrecht

Entity
Individual
Business address
Satsuma Pharmaceuticals, Inc., 400 Oyster Point Boulevard, Suite 221, 94080 South San Francisco, CA
Signature Ownership
/s/ Thomas P. O'Neil as Attorney in Fact for Detlef Albrecht, M.D.
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Detlef Albrecht has filed 16 SEC EDGAR filings since 4/13/2004

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Jun 7, 2022 Jun 3, 2022 001-39041
4 Open Document Open Filing FORM 4 Dec 7, 2020 Dec 3, 2020 001-39041
4 Open Document Open Filing FORM 4 Sep 3, 2020 Sep 1, 2020 001-39041
4 Open Document Open Filing FORM 4 Aug 5, 2020 Aug 3, 2020 001-39041
4 Open Document Open Filing FORM 4 Jul 2, 2020 Jul 1, 2020 001-39041
4 Open Document Open Filing FORM 4 Jun 2, 2020 Jun 1, 2020 001-39041
4 Open Document Open Filing FORM 4 May 6, 2020 May 5, 2020 001-39041
4/A Open Document Open Filing FORM 4/A May 6, 2020 Apr 14, 2020 001-39041
4/A Open Document Open Filing FORM 4/A May 6, 2020 Apr 1, 2020 001-39041
4 Open Document Open Filing FORM 4 Apr 16, 2020 Apr 14, 2020 001-39041
4 Open Document Open Filing FORM 4 Apr 3, 2020 Apr 1, 2020 001-39041
4 Open Document Open Filing FORM 4 Mar 12, 2020 Mar 11, 2020 001-39041
4 Open Document Open Filing FORM 4 Mar 6, 2020 Mar 4, 2020 001-39041
3 Open Document Open Filing FORM 3 SUBMISSION Sep 12, 2019 Sep 12, 2019 001-39041